Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
SUSAN M PODLOGAR Insider Profile
4 Followers
SUSAN M PODLOGAR, EVP HR at Metlife, holds 81.70K shares in Metlife (Ticker: MET), holds 193.92K shares in Tevogen Bio Holdings (Ticker: TVGN).
SUSAN M PODLOGAR has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that SUSAN M PODLOGAR holds in companies
Most Profitable Insider Trade
The most profitable trade made by SUSAN M PODLOGAR
SUSAN M PODLOGAR's Trading History
Metlife
Feb 29, 2024
EVP HR
Uninformative Sell
955.93K
$5.73M
Tevogen Bio Holdings
Feb 16, 2024
Director
Uninformative Buy
―
$132.84K
List of latest transactions for each holding click on a transaction to see SUSAN M PODLOGAR's performance on stock
You May Also Like
SUSAN M PODLOGAR insider profile FAQ
What is the percentage of profitable transactions made by SUSAN M PODLOGAR?
The percentage of profitable transactions made by SUSAN M PODLOGAR is ―.
What is the average return per transaction made by SUSAN M PODLOGAR?
The average return per transaction made by SUSAN M PODLOGAR is ―.
What stocks does SUSAN M PODLOGAR hold?
SUSAN M PODLOGAR holds: MET, TVGN stocks.
What was SUSAN M PODLOGAR’s latest transaction?
SUSAN M PODLOGAR latest transaction was an Uninformative Sell of $955.93K.
What was SUSAN M PODLOGAR's most profitable transaction?
SUSAN M PODLOGAR’s most profitable transaction was an Informative Sell of MET stock on December 22, 2022. The return on the trade was 5.10%.
What is SUSAN M PODLOGAR's role in Metlife?
SUSAN M PODLOGAR's role in Metlife is EVP HR.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.